Form 4 for HCA HCA Healthcare
Accepted 2021-11-02 00:00:00 ET · period of report 2021-10-29 · accession 0001209191-21-062528 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-02 | 2021-07-28 | HCA | RUTHERFORD BILL B | CFO, EVP | G - Gift | $0.00 | -200 | 49.5K | -0.4% | $0 |
| D | 2021-11-02 | 2021-10-29 | HCA | RUTHERFORD BILL B | CFO, EVP | M - OptEx | $47.97 | +78.6K | 128.1K | +159% | +$3.77M |
| D | 2021-11-02 | 2021-10-29 | HCA | RUTHERFORD BILL B | CFO, EVP | F - Tax | $250.46 | -40.1K | 88.0K | -31% | -$10.04M |
| DM | 2021-11-02 | 2021-10-29 | HCA | RUTHERFORD BILL B | CFO, EVP | M - OptEx | $0.00 | -78.6K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-28 | G | D | 200 | $0.00 | 49,457 | D | — | — | |
| 2 | Common | Common Stock | 2021-10-29 | M | A | 78,625 | $47.97 | 128,082 | D | — | — | |
| 3 | Common | Common Stock | 2021-10-29 | F | D | 40,073 | $250.46 | 88,009 | D | — | — | |
| 4 | Derivative | Stock Appreciation Right | 2021-10-29 | M | D | 36,125 | $0.00 | 0 | D | $47.97 · — to 2024-02-05 | 36,125 Common Stock | (F2) The stock appreciation rights vested at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the achievement of certain annual EBITDA performance targets. |
| 5 | Derivative | Stock Appreciation Right | 2021-10-29 | M | D | 42,500 | $0.00 | 0 | D | $47.97 · — to 2024-02-05 | 42,500 Common Stock | (F1) The stock appreciation rights vested in four equal annual installments beginning on February 5, 2015. |